MedTrace Logo

Three-dimensional Scanning of the Chest: a Comparison Between Three Different Imaging Modalities

NCT04279886 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2020-07-02

No results posted yet for this study

Summary

Recently, three-dimensional scanning of the torso has been proposed as an alternative for two-view chest radiographies and computed tomography to determine the severity of pectus excavatum without exposure to ionizing radiation. The range of three-dimensional scanning systems is broad with even varying systems being used within hospitals. Most of these scanning systems have been validated for accuracy and reproducibility, no comparison between these systems is known. In addition, severity measures of pectus excavatum, as well as other research outcomes, surgical planning techniques, and analysis methods are based on a single imaging system. It is subsequently essential to determine whether different imaging systems can be used interchangeably regarding accuracy and reproducibility.

The aim of this study was to assess the reproducibility and accuracy between three commonly used three-dimensional scanning systems.

Conditions

  • Chest Wall Disorder

Interventions

OTHER

Three-dimensional scans

All included healthy volunteers received 6 three-dimensional scans, utilizing 3 different scanning systems (2 scans per system)

Sponsors & Collaborators

  • Radboud University Medical Center

    collaborator OTHER

  • Zuyderland Medisch Centrum

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-20
Primary Completion
2020-03-20
Completion
2020-04-20

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04279886 on ClinicalTrials.gov